A. Bohan and J. Peter, Polymyositis and Dermatomyositis, New England Journal of Medicine, vol.292, issue.7, pp.344-347, 1975.
DOI : 10.1056/NEJM197502132920706

D. Stockton, V. Doherty, and D. Brewster, Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study, British Journal of Cancer, vol.21, issue.1, pp.41-45, 2001.
DOI : 10.1054/bjoc.2001.1699

R. Neri, B. Simone, V. Iacopetti, G. Iacopetti, P. Pepe et al., Cancerassociated myositis: a 35-year retrospective study of a monocentric cohort, Rheumatol Int. 10 déc, vol.4, 2013.

D. Legault, J. Mcdermott, A. Crous-tsanaclis, and G. Boire, Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome, J Rheumatol. janv, vol.35, issue.1, pp.169-171, 2008.

A. Rozelle, S. Trieu, and L. Chung, Malignancy in the Setting of the Anti-Synthetase Syndrome, JCR: Journal of Clinical Rheumatology, vol.14, issue.5, pp.285-288, 2008.
DOI : 10.1097/RHU.0b013e31817d116f

I. Marie, S. Josse, O. Decaux, S. Dominique, E. Diot et al., Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome, 739? 745. 9. O'Hanlon TP, 2012.
DOI : 10.1016/j.autrev.2012.01.006

URL : https://hal.archives-ouvertes.fr/hal-00872923

W. Hu, D. Chen, and H. Min, Study of 45 Cases of Nasopharyngeal Carcinoma with Dermatomyositis, American Journal of Clinical Oncology, vol.19, issue.1, pp.35-38, 1996.
DOI : 10.1097/00000421-199602000-00008

P. Teo, T. Tai, D. Choy, M. Diallo, A. Fall et al., Nasopharyngeal carcinoma with dermatomyositisDermatomyositis and polymyositis: 21 cases in Senegal Retrospective review of the clinical manifestations and outcomes in Puerto Ricans with idiopathic inflammatory myopathies Malignancy associated with dermatomyositis -a retrospective single-center study with 33 patients The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients):231? 249. 17. Callen JP. When and how should the patient with dermatomyositis or amyopathic dermatomyositis be assessed for possible cancer? Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study, 166? 168. 13. Ríos G, pp.471-474, 1989.

V. Limaye, C. Luke, G. Tucker, C. Hill, S. Lester et al., The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis. Medicine (Baltimore)Epidemiology and incidence of primary lung cancer in a region with low tobacco consumption: Guadeloupe (French West Indies) Data from the cancer registry, ):965? 971. 21. Fardet L, pp.91-97537, 2008.

P. Kadhel, E. Janky, L. Multigner, A. Forbes, S. Hall et al., Incidence and mortality of gynaecological cancers in Guadeloupe Chérin P, Marie I. [New diagnostic criteria and measuring outcome in polymyositis and dermatomyositis] Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study, Bull Cancer. févr Rev Med Interne. mai Ann Intern Med, vol.9626134, issue.2512, pp.157-164, 2001.